Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Vertex Pharmaceuticals Incorporated

TRADE

NASDAQ: VRTXHealthcare / Biotechnology / USA
185.48+0.03+0.02%Vol 784 0321Y Perf 19.57%
Oct 17th, 2018 16:00
BID185.48 ASK185.51
Open185.26 Previous Close185.45
Pre-Market185.25 After-Trading185.50
 -0.20 -0.11%  0.02 0.01%
Target Price
198.45 
Analyst Rating
Strong Buy 1.42
Potencial %
6.99 
Finscreener Ranking
★★★★+     58.29
Insiders Trans % 3/6/12M
-100/-100/-100 
Value Ranking
★★★+     53.51
Insiders Value % 3/6/12M
-100/-100/-100 
Growth Ranking
★★★★★     79.18
Insiders Shares Cnt. % 3/6/12M
-100/-100/-100 
Income Ranking
 —    -
Market Cap (mil)47 401 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
83.84 
Earnings Date
24th Oct 2018

Today's Price Range

181.72185.84

 

52wk Range

136.50194.92

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Month
4.72%
3 Months
2.40%
6 Months
13.54%
1 Year
19.57%
3 Years
62.25%
5 Years
140.70%

Quotes

Name / TickerPriceChg.Chg.%
VRTX185.480.03000.02
AAPL221.19-0.9600-0.43
GOOG1 115.69-5.5900-0.50
MSFT110.71-0.2900-0.26
XOM81.500.30000.37
WFC54.460.73001.36
JNJ139.462.90002.12
FB159.420.64000.40
GE12.190.09000.74
JPM109.831.21001.11
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 3.40
Current Ratio 5.80
Long Term Debt to Total Capital 0.17
Total Debt to Equity 0.21
Interest Coverage 3.70
Leverage Ratio 1.60
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin87.30
EBIT Margin6.60
EBITDA Margin9.10
Pre-tax Profit Margin-53.20
Profit Margin27.23
ValuationValueIndustryS&P 500US Markets
PE Ratio 113.30
PB Ratio 17.25
PS Ratios 23.07
Price to Cash Flow 48.00
Price to Free Cash Flow 66.20
Cash Flow Per Share 3.78
Price to Tangible Book17.78
Book Value per Share10.51
Enterprise Value (in ths.)42 716 600
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-26.34
ROE last 12 Months 18.90
Return on Assets (5Y Avg) -8.10
ROA last 12 Months 10.79
Return on Capital (5Y Avg) -15.07
ROC last 12 Months 16.30
Return on invested Capital Q 6.84
Return on invested Capital Y12.85
Assets Turnover0.50
Receivables Turnover6.00
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)2 008 870
Revenue per Share 7.86
Revenue Growth 3 Years 34.99
Revenue Growth 5 Years 24.74
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 20180.400.6255.00
Q01 20180.280.5492.86
Q04 20170.290.3210.34
Q03 20170.040.24500.00
Q02 20170.060.1066.67
Q01 20170.040.13225.00
Q04 2016-0.010.131 400.00
Q03 2016-0.06-0.09-50.00
Earnings Per EndEstimateRevision %Trend
9/2018 QR0.6838.78Positive
12/2018 QR0.7427.59Positive
12/2018 FY2.5028.87Positive
12/2019 FY3.266.19Positive
Next Report Date24th Oct 2018
Estimated EPS Next Report0.69
Estimates Count8
EPS Growth Next 5 Years %39.50
Volume Overview
Volume784 032
Shares Outstanding (in ths.)255 560
Trades Count3 884
Dollar Volume105 500 524
Avg. Volume1 520 085
Avg. Weekly Volume1 298 624
Avg. Monthly Volume1 239 341
Avg. Quarterly Volume1 134 220

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

41%59%

Bearish Bullish

56%44%

Bearish Bullish

60%40%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
14 (70.00 %)
14 (70.00 %)
14 (73.68 %)
Moderate Buy
3 (15.00 %)
3 (15.00 %)
3 (15.79 %)
Hold
3 (15.00 %)
3 (15.00 %)
2 (10.53 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.42
Strong Buy
1.42
Strong Buy
1.34

There are no comments yet.

News

x